You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞信窝轮》港交偏软里康急跌,留意港交购25062、里康牛66503
阿思达克 06-07 13:10
港交所(0388)周一跌约2%,低位曾跌穿470元。500元关口仍具明显阻力,并观望460元水平能否建立支持。看好可留意港交购25062,行使价568.50元,21年10月到期。或港交牛65783,收回价458.00元,行使价456.00元,21年12月到期。相反看淡可留意港交沽13140,行使价424.80元,21年10月到期。或港交熊59130,收回价500.00元,行使价502.00元,21年7月到期。

友邦保险(1299)跌逾1%,低位跌穿97元。百元关或已建成阻力,支持或参考95元水平。看好可留意友邦购11296,行使价111.48元,21年12月到期。相反看淡则可留意友邦沽20393,行使价93.88元,21年12月到期。

阿里健康(0241)最多跌逾4%,低位跌穿19元。看好可留意里康购13662,行使价21.08元,21年12月到期。或里康牛66503,收回价17.38元,行使价16.78元,21年12月到期。相反看淡可留意里康熊66506,收回价21.28元,行使价21.88元,21年12月到期。

药明生物(2269)一度低走逾3%,回落至120元以下。看好可留意药明购28169,行使价139.88元,21年9月到期。或药明牛65786,收回价108.88元,行使价106.88元,21年11月到期。相反看淡可留意药明熊59539,收回价135.00元,行使价138.00元,21年10月到期。

忧虑广东省疫情反弹,餐饮股捱沽。九毛九(9922)曾泻逾8%,低见26.75元。观望反弹,可考虑九毛购26261,行使价33.88元,21年11月到期。

海底捞(6862)周一低位暂守40元,看好可留意海捞购25351,行使价48.43元,21年12月到期。主要为海底捞提供配料的颐海国际(1579)曾跌逾3%,创53.2元的52周低位後回稳。看好反弹可考虑颐海购12721,行使价71.88元,22年4月到期。

以上产品资料来源: 彭博资讯及瑞信网站cswarrants.com

(本结构性产品并无抵押品)

《瑞信香港认股证及牛熊证销售主管何启聪》

免责声明:笔者为瑞士信贷(香港)有限公司的代表 ,并身为证监会持牌人,并无持有相关上市公司的任何财务权益。本文内容仅供参考,并不构成要约、建议或促使任何人士提呈买卖或认购任何证券。结构性产品价格可急升或急跌,投资者或会蒙受全盘损失。本产品并无抵押品。如发行人无力偿债或违约,投资者可能无法收回部份或全部应收款项。牛熊证备强制赎回机制而可能被提早终止,届时(i)N类牛熊证投资者将不获发任何金额;而(ii)R类牛熊证之剩余价值可能为零。有关恒生指数,恒生中国企业指数或恒生科技指数的免责声明,请参阅上市文件。有关纳斯达克100指数的免责声明,请参阅上市文件。过往表现并不反映将来表现。投资前,投资者应了解风险,并谘询专业顾问及查阅有关上市文件。瑞信之联属公司Credit Suisse Securities (Hong Kong) Limited为结构性产品之流通量提供者,亦可能是唯一报价者。本文任何内容概不构成投资、法律、会计或税务意见、并无声明任何投资或策略适合或符合阁下的个别情况。结构性产品交投量并不是结构性产品表现的指标,投资者不应仅依赖交投量历史高位数据以厘定结构性产品日後的表现。~

重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account